FDA Approved: MOZOBIL — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved Mozobil (plerixafor) under an Original Application (NDA022311) to mobilize hematopoietic stem cells in combination with G-CSF for autologous transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• Mozobil (plerixafor)

Snippet

ORIG AP for MOZOBIL (PLERIXAFOR)